EDUCATIONDoctor of Philosophy,Pharmaceutical Outcomes and Policy, University of Florida, Gainesville,FL,USA,December2018Masterof Science,Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL,USA,May 2018Doctor of Pharmacy, TheRudolph H.Raabe College of Pharmacy, Ohio Northern University,Ada, OH,USA,Dean’s ListHonor, May2013Bachelor’s in pharmacy,College of Pharmacy, King Saud University, Riyadh, Saudi Arabia,April 2007PROFESSIONAL EXPERIENCE
Assistant Professor,Pharmacy Practice Department,Schoolof Pharmacy, Qassim University,Saudi Arabia, 2019–PresentMember,Higher Pharmacovigilance Advisory Committee, Saudi Food and DrugAuthority, Saudi Arabia, 2019-PresentLecturer,Pharmacy Practice Department,Schoolof Pharmacy, Qassim University, SaudiArabia, 2007–2019AWARDSAND RECOGNITION▪Finalist, Three Minute Thesis Competition(3MT), University of Florida, 2018▪Top 10% poster award,International Society of Pharmacoeconomics and Outcomes Research(ISPOR) Annual Meeting, Baltimore, MD,USA,2018▪Top 25 articles for the year,American Journal ofHealth-System Pharmacy, 2017▪Poster Finalist Award, 21STInternational Society of Pharmacoeconomics and OutcomesResearch (ISPOR) Annual Meeting, Washington, D.C.,USA2016▪Dr. Bruce Burton International Student Involvement Award, Ohio Northern University,Ada,OH,USA,2013▪Outstanding Academic Performance Award, College of Pharmacy, Ohio NorthernUniversity, Ada, OH,USA,2010▪Best Summer Trainee AwardatIskan Clinic, King Abdulaziz Medical City, Riyadh, SaudiArabia, 2006▪First Award for ArabianGulf Countries’ Story Authors, National Council for Culture,Art,and Heritage,GCC,2005

AbdullahA.Alalwan2LICENSES/CERTIFICATIONS•ConsultantPharmacist License, SaudiArabia[07-R-P-0027745]•Certified ItemsAuthor, Saudi Commission for Health Specialties•OhioBoard ofPharmacy Intern’sLicense•Health Insurance Portability and Accountability Act (HIPAA) Certification•Advanced Cardiovascular Life Support (ACLS) Certification•Cardiopulmonary Resuscitation/BasicLife Support•Occupational Safety and Health Administration (OSHA)TEACHING EXPERIENCEQassim University•PHP 341–Ethics in Pharmacy•PHP 231–EvidenceBased Pharmacy and Biostatistics•PHP 410–Pharmacotherapy•PHP 361–Integrated Pharmacotherapy–Cardiovascular Course•PHP 426–Pharmacy Law•PHP 111–Introduction toPharmacy PracticeUniversity of Florida•PHA 5742–ProfessionalCommunications•PHA 6268–Pharmacoepidemiology and Sciences of Drug SafetyPUBLICATIONS•Alalwan AA,Friedman J,Alfayez OM,Hartzema A.“Drug absorption in bariatric surgerypatients: a narrative review.”Health ScienceReports.(2022)5:e605.•Alalwan AA.“Influenza Vaccine Utilization: A Comparison between Urban and RuralCounties in Florida.”Vaccines. (2022) 10(5):669•Alahmad AA, AlkheziOS, Alfayez OM, Aseeri M, Mahrous AJ, Alhossan AM, Fanikos J,Alalwan AA.“Characteristics of the ideal clinical pharmacy residency candidate: a surveyof residency program directors and preceptors in Saudi Arabia”Saudi PharmaceuticalJournal.30(2022)66–71.•Alalwan AA, Friedman J, Park H, Segal R, Brumback B, HartzemaA.“US Nationaltrendsin bariatric surgery: A decade of Study.”Surgery(2021): 13–17.

AbdullahA.Alalwan3PUBLICATIONS(Continued)•Alharbi I, Alharbi H, Almogbel Y,Alalwan AA,and Alhowail A.“Effect of metformin ondoxorubicin-induced memory dysfunction.”Brain Sciences. (2020) 10:152.•Alalwan AA, Voils SA,andHartzema AG.“Trends in utilization of warfarin and direct oralanticoagulants in older adult patients with atrial fibrillation.”AmericanJournal ofHealth-SystemPharmacy.(2017)74:1237–44.[Top 25 articles of AJHP in 2017]PODIUMPRESENTATIONS•Abdullah Alalwan“Substandard Medications and Patient Safety,”Speaker, Drugs Safety andPharmacovigilance Conference (SECURE21), The Supreme Council of Health, Bahrain, October2021•Abdullah Alalwan“Post-Marketing Drug Safety Webinar,”Speaker,Saudi Drug and FoodAuthority, Riyadh, Saudi Arabia, September 2021•Abdullah Alalwan“Considerations to Formulate Causal Research Question,”Speaker,Principles of Causal Inference and Pharmacoepidemiologic Research Summer Workshop,International Society for Pharmacoepidemiology (ISPE-GRIG). Riyadh, Saudi Arabia,August 2021•Abdullah Alalwan“Comparative Safety Profiles of Biosimilars vs. Originators,” Speaker.Saudi Drug Security Congress. Riyadh, Saudi Arabia, June2021•Abdullah Alalwan“Scientific Literature Review”. Speaker. Basics of Scientific ResearchWorkshop. College of Pharmacy, Taibah University, March 2021•Abdullah Alalwan“Drug Repurposing Using Real-World Evidence During Pandemics,”PanelDiscussionSpeaker, Saudi International Pharmaceutical Sciences Meeting and•Abdullah Alalwan“Big Data and Healthcare Transformation”, Podium presentation, SaudiInternet of Things Conference, King Abdulaziz City for Science and Technology, February2020•Abdullah Alalwan“Dataandstatistical analysis”, Podium presentation, ThePharmaceutical Education Initiative(ResearchWorkshop),American Association ofPharmaceuticalScientists (Saudi Group)andtheSaudi Society of Medication Education,Riyadh, Saudi Arabia,October 2019POSTERPRESENTATIONS•Abdullah Alalwan,Yasser Albogami,Zakiyah Alkherb, Amani Alshahrani, Waad Aljrrari, and AdelAlrwisan.“The use of real-world data in research in the GCC Countries: A descriptive study.”,Poster presentation at the37thInternationalConference on Pharmacoepidemiology & TherapeuticRisk Management (ICPE),ICPE2021,August2021•Abdullah Alalwan,Jeffrey Friedman,Haesuk Park, Richard Segal,Abraham G. Hartzema.“Comparativesafety of sleevegastrectomy and Roux-en-Y in adult patients”,Posterpresentation atInternational Society of Pharmacoeconomics and Outcomes Research (ISPOR)ofEurope,Copenhagen, Denmark, November 2019

AbdullahA.Alalwan4POSTERPRESENTATIONS(Continued)•Abdullah Alalwan,Jeffrey Friedman, Haesuk Park, Abraham Hartzema.“National trends inutilization of bariatric surgery”,Poster presentation at the23rdAnnual InternationalMeeting, International Society of Pharmacoeconomics and Outcomes Research (ISPOR),Maryland, MD, May 2018•Abdullah Alalwan, Stacy Voils, Abraham Hartzema.“Five years since the first direct oralanticoagulants approval: What do we know about their utilization?”,Poster presentation atthe 21thAnnual International Meeting, International Society of Pharmacoeconomics andOutcomes Research (ISPOR), Washington, DC, May 2016•Abdullah Alalwan, Stacy Voils, Abraham Hartzema.“Trends in theutilization of warfarinand the new oral anticoagulants in atrialfibrillation patients.”Poster presentation atthe 29thAnnual College of Pharmacy’s Research Showcase, University of Florida, Gainesville, FL,February2016•Abdullah Alalwan,Abraham Hartzema.“Influenza vaccine utilization: a comparison betweenurban and rural counties in Florida.”Poster presentation at the 28thAnnual College ofPharmacy’s Research Showcase, University of Florida, Gainesville, FL, February2015•Abdullah Alalwan, Stacy Voils,Abraham Hartzema.“Trends in the utilization of warfarinand the new oral anticoagulants in atrial fibrillation patients.”,Poster presentation at the31STInternationalConference on Pharmacoepidemiology & Therapeutic Risk Management(ICPE),ICPE2015, Boston, MA. August2015•Abdullah Alalwan,Abraham Hartzema.“Influenza vaccine utilization: a comparisonbetween urban and rural counties in Florida.”Poster presentation at the31STInternationalConference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), ISPE,Boston, MA. August2015PROFESSIONAL AFFILIATIONS•International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2013–Present•International Society for Pharmacoepidemiology (ISPE), 2014–Present•Student National Pharmaceutical Association (SNPhA), 2009-2013•American Society of Health-System Pharmacists (ASHP), 2012-2014•Ohio Society of Health-System Pharmacists (OSHP),2012-2014•Student Society of Health-System Pharmacists (SSHP), 2012-Present•Saudi Pharmaceutical Society (SPS), 2003-2007•Saudi Clinical Pharmacy Club, 2005-2007PROFESSIONAL TRAINING•Advanced Pharmacy Practice Experience (APPEs)July 2012-April2013▪Community Pharmacy, Rite Aid Pharmacy, Ada, OH▪Pediatric Pain, Nationwide Children’s Hospital, Columbus, OH▪Research, Ohio Northern University, Ada, OH▪Diabetic Clinic, Bluffton Physicians Inc., Bluffton, OH▪Ambulatory Care, Grove City Family Practice, Grove City, OH▪Medication Safety, Riverside MethodistHospital, Columbus, OH

AbdullahA.AlalwanPROFESSIONAL TRAINING(Continued)▪General Medicine, Lake Health TriPoint Hospital, Cleveland, OH▪Geriatric, Institutional Care Pharmacy, Tiffin, OH▪Hospital Pharmacy, Mary Rutan Hospital, Bellefontaine, OH•Clinical Rotations, King Abdulaziz Medical City,Riyadh, Saudi Arabia, 2007.▪Rotation with clinical pharmacists in: Coumadin/ Anticoagulation clinic, oncology clinic,internal medicine clinic, ICU, and organ transplantation clinic▪Worked in Anticoagulation Clinic three days a week to monitor patients; checked INR,reviewed Warfarin dose and double checked any medication or diet changes▪Counseled patients on possible drug-drug interactions between their current medicationsand Warfarin▪Presented at P&T committee meeting with preceptor.Attended and participated in dailyrounds in oncology, ICU,and internal medicine wards.Counseled liver and kidneytransplant patients on post-transplant medications•Summer Training Program,King Abdulaziz Medical City,Riyadh, Saudi Arabia, 2006▪Worked at inpatient pharmacy; prepared and delivered orders to wards▪Worked at outpatient pharmacy; dispensed prescriptions and counseled patients▪Prepared patient education materials such as posters, pamphlets, and newsletters▪Worked in compounding pharmacy;preparation ofpediatric prescriptions•Introductory Pharmacy PracticeExperience, King Abdulaziz Medical City, Riyadh, SaudiArabia, 2010▪Reviewed inpatient files and monitored medications daily▪Counseled patientsonmedications before discharge▪Completed a new drug evaluation about RenagelPROFESSIONAL SKILLS•English Language: Excellent•Statistical Analysis SystemProgrammingSAS(Data Analysis and Statistics Software):AdvancedEntrepreneurship•Co-founder and co-host of Alhawi Podcast)بودكاست الحاوي, Weekly Arabic medical(, Weekly Arabic medicalprogram broadcasted online via Podcast applications and YouTube, 2019-Present